ICD-10 Coding for Prostate Cancer with Metastases(C79.51, C79.51B, C79.51S)
Learn how to accurately code prostate cancer with metastases using ICD-10, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Prostate Cancer with Metastases
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C61 | Malignant neoplasm of prostate | Use when prostate cancer is confirmed as the primary site. |
|
| C79.51 | Secondary malignant neoplasm of bone | Use when metastases to bone are confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutProstate Cancer with Metastases
Documentation & Coding Risks
Avoid these common issues when documenting Prostate Cancer with Metastases.
Generalizing metastatic sites
Impact
Clinical: Inaccurate treatment planning, Regulatory: Non-compliance with documentation standards, Financial: Potential billing errors
Mitigation
Detail each metastatic site, Use specific codes for each site
Omitting metastasis codes
Impact
Reimbursement: Incorrect DRG assignment, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate patient records
Mitigation
Always pair C61 with appropriate C79.x codes.
Metastasis documentation
Impact
Incomplete documentation of metastatic sites
Mitigation
Ensure all sites are documented with imaging and biopsy confirmation.